Kinarus Therapeutics Holding Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Alexander Bausch
Chief executive officer
CHF291.4k
Total compensation
| CEO salary percentage | 51.8% |
| CEO tenure | 1.8yrs |
| CEO ownership | n/a |
| Management average tenure | 1.8yrs |
| Board average tenure | less than a year |
Recent management updates
Recent updates
CEO
Alexander Bausch (61 yo)
1.8yrs
Tenure
CHF291,381
Compensation
Dr. Alexander Bausch is Chief Executive Officer, Co-Founder and Director of Strekin AG from August 2014. Dr. Bausch is Chief Executive Officer of Kinarus Therapeutics Holding AG since June 02, 2022 and ser...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 1.8yrs | CHF291.38k | no data | |
| Chief Clinical Development Officer | 1.8yrs | CHF136.73k | 0.67% CHF 25.9k | |
| Chief Medical Officer | 1.8yrs | CHF136.73k | 0.21% CHF 8.2k | |
| COO & Head of Research | 1.8yrs | no data | no data |
1.8yrs
Average Tenure
Experienced Management: KNRS's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board | less than a year | no data | no data | |
| Director | less than a year | no data | no data | |
| Director | less than a year | no data | no data | |
| Director | 1.8yrs | no data | 4.18% CHF 160.9k |
0.3yrs
Average Tenure
Experienced Board: KNRS's board of directors are not considered experienced ( 0.3 years average tenure), which suggests a new board.